Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,294.96 -710.39 (-1.11%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
SkinBioTherapeutics plc (SBTX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:27PM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 18.54M |
| Enterprise value | 15.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 100.01 |
| Price/book (mrq) | 5.08 |
| Enterprise value/revenue | 97.69 |
| Enterprise value/EBITDA | -5.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.61 |
| 52-week change 3 | -40.32% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 29.50 |
| 52-week low 3 | 7.00 |
| 50-day moving average 3 | 9.42 |
| 200-day moving average 3 | 16.47 |
Share statistics
| Avg vol (3-month) 3 | 707.86k |
| Avg vol (10-day) 3 | 165.72k |
| Shares outstanding 5 | 200.38M |
| Implied shares outstanding 6 | 200.38M |
| Float 8 | 149.08M |
| % held by insiders 1 | 27.02% |
| % held by institutions 1 | 11.50% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,300.69% |
Management effectiveness
| Return on assets (ttm) | -61.18% |
| Return on equity (ttm) | -118.63% |
Income statement
| Revenue (ttm) | 161.65k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | 38.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -3M |
| Net income avi to common (ttm) | -2.88M |
| Diluted EPS (ttm) | -0.02 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.84M |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 97.05k |
| Total debt/equity (mrq) | 2.66% |
| Current ratio (mrq) | 6.57 |
| Book value per share (mrq) | 0.02 |
Cash flow statement
| Operating cash flow (ttm) | -3.02M |
| Levered free cash flow (ttm) | -2.25M |
© 2024 Yahoo. All rights reserved.